secwatch.observer — SEC 8-K summary
======================================

Issuer:     4D Molecular Therapeutics, Inc. (FDMT)
CIK:        0001650648
Form:       8-K
Filed at:   2024-02-09T23:59:59+00:00
Accession:  0001193125-24-030203
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

4D Molecular Therapeutics raises ~$281.4M in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 6,586,015 shares at $29.50/share and pre-funded warrants for 3,583,476 shares at $29.4999 each.
- Underwriters granted 30-day option to purchase up to 1,525,423 additional shares.
- Net proceeds ~$281.4M after underwriting discounts and expenses; offering closed Feb 9, 2024.
- Directors and officers subject to lock-up until April 6, 2024 without underwriter consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650648/000119312524030203/0001193125-24-030203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650648/000119312524030203/d185041d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-030203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer